Veerhealth Care Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bhavin Shah

Algemeen directeur

₹1.0m

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	11.5yrs
Eigendom CEO	1.7%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	5.7yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Bhavin Shah's beloning veranderd ten opzichte van Veerhealth Care's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	₹2m
Mar 31 2024	₹1m	₹1m	₹4m
Dec 31 2023	n/a	n/a	₹19m
Sep 30 2023	n/a	n/a	₹21m
Jun 30 2023	n/a	n/a	₹18m
Mar 31 2023	₹1m	₹1m	₹16m
Dec 31 2022	n/a	n/a	₹2m
Sep 30 2022	n/a	n/a	₹762k
Jun 30 2022	n/a	n/a	-₹535k
Mar 31 2022	₹960k	₹960k	-₹736k
Dec 31 2021	n/a	n/a	₹501k
Sep 30 2021	n/a	n/a	-₹193k
Jun 30 2021	n/a	n/a	₹4m
Mar 31 2021	₹960k	₹960k	₹4m
Dec 31 2020	n/a	n/a	-₹711k
Sep 30 2020	n/a	n/a	₹99k
Jun 30 2020	n/a	n/a	₹2m
Mar 31 2020	₹1m	₹1m	₹3m
Dec 31 2019	n/a	n/a	₹4m
Sep 30 2019	n/a	n/a	₹6m
Jun 30 2019	n/a	n/a	₹2m
Mar 31 2019	₹910k	₹910k	₹2m
Dec 31 2018	n/a	n/a	-₹391k
Sep 30 2018	n/a	n/a	-₹1m
Jun 30 2018	n/a	n/a	₹2m
Mar 31 2018	₹770k	₹770k	₹1m

Compensatie versus markt: De totale vergoeding ($USD 12.33K ) Bhavin } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.81K ).

Compensatie versus inkomsten: De vergoeding van Bhavin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Bhavin Shah (43 yo)

11.5yrs

Tenure

₹1,040,000

Compensatie

Mr. Bhavin Satish Shah served as Non-Executive Director at Veer Energy & Infrastructure Limited until August 14, 2024. Mr. Shah has been Managing Director at Veerhealth Care Limited since May 22, 2013 and...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Bhavin Shah	MD & Whole Time Director	11.5yrs	₹1.04m	1.69% ₹ 7.0m
Shruti Shah	Executive Director	10.2yrs	₹585.00k	geen gegevens
Yogesh Shah	Non-Executive Chairman	13.4yrs	geen gegevens	18.56% ₹ 77.5m
Prakashbhai Shah	Non-Executive Independent Director	1.3yrs	₹1.00k	0.018% ₹ 75.2k
Chetan Mehta	Non-Executive Independent Director	1.3yrs	₹2.00k	geen gegevens
Nilesh Shah	Non-Executive Independent Director	1.3yrs	₹2.00k	geen gegevens

5.7yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 511523 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.7 jaar).

Veerhealth Care Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Veerhealth Care Limited, Annual General Meeting, Sep 30, 2024

Non-Executive Chairman recently bought ₹1.8m worth of stock

Non-Executive Chairman recently bought ₹3.1m worth of stock

Veerhealth Care Limited, Annual General Meeting, Sep 11, 2023

Insufficient new directors

Veerhealth Care Limited, Annual General Meeting, Sep 30, 2022

Recent updates

Veerhealth Care Limited to Report Q2, 2025 Results on Nov 14, 2024

New minor risk - Share price stability

Veerhealth Care Limited, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: EPS: ₹0.06 (vs ₹0.17 in 1Q 2024)

Veerhealth Care Limited to Report Q1, 2025 Results on Aug 14, 2024

Full year 2024 earnings released: EPS: ₹0.21 (vs ₹0.79 in FY 2023)

Veerhealth Care Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 16%

Non-Executive Chairman recently bought ₹1.8m worth of stock

Non-Executive Chairman recently bought ₹3.1m worth of stock

Veerhealth Care Limited has filed a Follow-on Equity Offering in the amount of INR 249.98095 million.

Investor sentiment improves as stock rises 18%

New major risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: ₹0.09 (vs ₹0.23 in 3Q 2023)

Veerhealth Care Limited to Report Q3, 2024 Results on Feb 10, 2024

Investor sentiment improves as stock rises 23%

New major risk - Share price stability

Investor sentiment improves as stock rises 25%

Second quarter 2024 earnings released: EPS: ₹0.19 (vs ₹0.095 in 2Q 2023)

First quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.12 in 1Q 2023)

Veerhealth Care Limited, Annual General Meeting, Sep 11, 2023

Veerhealth Care Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 44%

Full year 2023 earnings released: EPS: ₹1.52 (vs ₹0.11 loss in FY 2022)

Veerhealth Care Limited to Report Q4, 2023 Results on May 22, 2023

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹0.46 (vs ₹0.25 in 3Q 2022)

Veerhealth Care Limited to Report Q3, 2023 Results on Feb 13, 2023

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹0.19 (vs ₹0.04 in 2Q 2022)

Veerhealth Care Limited to Report Q2, 2023 Results on Nov 10, 2022

Now 20% undervalued

First quarter 2023 earnings released: EPS: ₹0.12 (vs ₹0.07 in 1Q 2022)

Veerhealth Care Limited, Annual General Meeting, Sep 30, 2022

Veerhealth Care Limited to Report Q1, 2023 Results on Aug 12, 2022

Veerhealth Care Limited to Report Q4, 2022 Results on May 30, 2022

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Veerhealth Care Limited to Report Q3, 2022 Results on Feb 11, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS ₹0.07 (vs ₹0.09 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹0.55 (vs ₹0.46 in FY 2020)

Third quarter 2021 earnings released: EPS ₹0.15 (vs ₹0.26 in 3Q 2020)

New 90-day high: ₹9.12

Veerhealth Care Limited to Report Q3, 2021 Results on Jan 28, 2021

New 90-day low: ₹7.60

First quarter earnings released

Veerhealth Care Limited to Report Q1, 2021 Results on Sep 02, 2020

Veerhealth Care Limited to Report Q4, 2020 Results on Jul 30, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd